Patient Guide: A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 123 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04770896
Status: ACTIVE_NOT_RECRUITING
Condition: Unresectable Hepatocellular Carcinoma
Phase: PHASE3

Find a Study Location Near You

This study is available at 123 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Innsbruck,
  • Salzburg,
  • Sankt Pölten,
  • • And 120 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily